AARTIIND Share Price Today - Aarti Industries on NSE/BSE
NiveshIQ
NSE: AARTIDRUGS · Healthcare
Aarti Drugs Ltd.
₹414.00▼ ₹3.55 (-0.85%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on AARTIDRUGS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Aarti Drugs Ltd.
Aarti Drugs Limited is a diversified pharmaceutical manufacturer that produces active pharmaceutical ingredients (APIs), intermediates, specialty chemicals, and finished formulations for both domestic and international markets. Its core revenue drivers include high‑margin APIs such as diclofenac derivatives, fluoroquinolone antibiotics, and antidiabetic agents like metformin and teneligliptin, which collectively accounted for ₹2678 crore in revenue during FY27. The company has recently expanded its production capacity for diclofenac and fluoroquinolones, positioning it to meet rising demand from global contract manufacturing agreements. Aarti Drugs maintains a competitive edge through a robust supply chain, strong quality certifications, and a diversified product portfolio that reduces rel
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,529 Cr -6.90% | ₹2,387 Cr -5.60% | ₹2,565 Cr +7.47% |
| EBITDA Margin | 12.52% | 12.03% | 12.05% |
| Net Profit | ₹171.42 Cr +3.07% | ₹168.16 Cr -1.90% | ₹194.92 Cr +15.91% |
| EPS | ₹18.56 | ₹18.35 | ₹21.36 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Aarti Pharmalabs Limited (AARTIPHARM.NS) Stock Price, News, Quote & History
Aarti Pharmalabs Share Price - Live NSE: AARTIPHARM Stock Price & Chart
🔒
+ 3 more stories about Aarti Drugs Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹703 Cr, PAT ₹50 Cr, EPS ₹5.49, EBITDA margin 14.1%. Growth context: revenue QoQ -2.4%, PAT QoQ -9.3%.
Management highlights domestic demand, export traction, margin discipline, new capacity addition, and capex deployment a...
FY26 (last completed FY): revenue ₹2, 565 Cr, PAT ₹195 Cr, EBITDA margin 12.2%, EPS ₹21.36. Year-on-year: revenue YoY +7...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Ventive Hospitality Ltd.Vijaya Diagnostic Centre Ltd.Viyash Scientific Ltd.Wockhardt Ltd.Yatharth Hospital & Trauma Care Services Ltd.Zydus Lifesciences Ltd.Aarti Pharmalabs Ltd.Abbott India Ltd.Acutaas Chemicals Ltd.Advanced Enzyme Tech Ltd.Ajanta Pharmaceuticals Ltd.Akums Drugs and Pharmaceuticals Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for AARTIDRUGS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track AARTIDRUGS alongside your other holdings
Unlock full AARTIDRUGS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Aarti Drugs Ltd.?
NiveshIQ detects active intelligence signals for Aarti Drugs Ltd. (AARTIDRUGS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Aarti Drugs Ltd.?
Aarti Drugs Ltd. operates in the Healthcare sector with a market capitalisation of ₹375,347.9L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.